Cargando…

Catastrophic Kawasaki disease unresponsive to IVIG in a 3-month-old infant: a diagnostic and therapeutic challenge

The present report describes the severe evolution of Kawasaki disease in a three-month-old infant. The ailment was initially atypical in its presentation, with the patient exhibiting only persistent fever in association with a progressive lethargy and maculopapular rash on the face, trunk and limbs...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Magalhães, Cristina Medeiros Ribeiro, Alves, Natália Ribeiro de Magalhães, de Melo, Adriana Valença, Junior, Clodoaldo Abreu da Silveira, Nόbrega, Yanna Karla de Medeiros, Gandolfi, Lenora, Pratesi, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598686/ https://www.ncbi.nlm.nih.gov/pubmed/22929725 http://dx.doi.org/10.1186/1546-0096-10-28

Ejemplares similares

The possible link between coeliac and Kawasaki diseases in Brazil: a cross-sectional study
por: dos Santos Domingues, Alessandra, et al.
Publicado: (2018)

Clinical Manifestations of Kawasaki Disease at Different Age Spectrum: A Ten-Year Study
por: Medeiros R. de Magalhães, Cristina, et al.
Publicado: (2020)

Content Validation and Semantic Evaluation of a Check-List Elaborated for the Prevention of Gluten Cross-Contamination in Food Services
por: Farage, Priscila, et al.
Publicado: (2017)

Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species
por: Correia, Amabel Fernandes, et al.
Publicado: (2016)

Presence of DQ2.2 Associated with DQ2.5 Increases the Risk for Celiac Disease
por: Almeida, Lucas Malta, et al.
Publicado: (2016)

Endothelial dysfunction in children with type 1 diabetes mellitus
por: do Nascimento, Antonella Márcia Mercadante de Albuquerque, et al.
Publicado: (2017)

Correlation between the Level of Inflammatory Cytokines and Prognosis in Children with IVIG-sensitive Kawasaki Disease and IVIG-resistant Kawasaki Disease
por: Zhang, Hao, et al.
Publicado: (2022)

A Replication Study for Association of ITPKC and CASP3 Two-Locus Analysis in IVIG Unresponsiveness and Coronary Artery Lesion in Kawasaki Disease
por: Kuo, Ho-Chang, et al.
Publicado: (2013)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Self-Reported Non-Celiac Gluten Sensitivity in Brazil: Translation, Cultural Adaptation, and Validation of Italian Questionnaire
por: Gadelha de Mattos, Yanna A., et al.
Publicado: (2019)

Therapeutic Window of Intravenous Immunoglobulin (IVIG) and its correlation with IVIG-resistant in Kawasaki Disease: a retrospective study
por: Cai, Jiang Hui, et al.
Publicado: (2022)

Factors Predicting Resistance to Intravenous Immunoglobulin and Coronary Complications in Kawasaki Disease: IVIG Resistance in Kawasaki Disease
por: Han, Ji Whan
Publicado: (2017)

Profile of resistance to IVIG treatment in patients with Kawasaki disease and concomitant infection
por: Dionne, Audrey, et al.
Publicado: (2018)

Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease
por: Zhang, Rui Long, et al.
Publicado: (2020)

Extracts of Morus nigra L. Leaves Standardized in Chlorogenic Acid, Rutin and Isoquercitrin: Tyrosinase Inhibition and Cytotoxicity
por: de Freitas, Marcela Medeiros, et al.
Publicado: (2016)

DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease
por: Portman, Michael A, et al.
Publicado: (2013)

A Case of Kawasaki Disease with Coronary Aneurysm Responding to the 4th IVIG Treatment
por: Kim, Ju Young, et al.
Publicado: (2014)

Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
por: Crayne, Courtney B., et al.
Publicado: (2019)

Chronic, eventually fatal, Kawasaki-like disease in an adult with spondylarthropathy responding to IVIG therapy
por: Soltner, Elise, et al.
Publicado: (2009)

An Update on Reports of Atypical Presentations of Kawasaki Disease and the Recognition of IVIG Non-Responder Children
por: Conte, Cristiano, et al.
Publicado: (2023)

Association between P2RY12 Gene Polymorphisms and IVIG Resistance in Kawasaki Patients
por: Wang, Zhouping, et al.
Publicado: (2020)

Distinctive serum lipidomic profile of IVIG-resistant Kawasaki disease children before and after treatment
por: Chen, Zhen, et al.
Publicado: (2023)

Atherosclerosis in young Brazilians suffering violent deaths: a pathological study
por: Modelli, Manoel ES, et al.
Publicado: (2011)

Measuring Quality of Life in Parents or Caregivers of Children and Adolescents with Celiac Disease: Development and Content Validation of the Questionnaire
por: Abreu Paiva, Liliane Maria, et al.
Publicado: (2019)

Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease
por: Piram, Maryam, et al.
Publicado: (2020)

Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease
por: Kitoh, Toshiyuki, et al.
Publicado: (2021)

Screening for celiac disease in 1st degree relatives: a 10-year follow-up study
por: Uenishi, Rosa H, et al.
Publicado: (2014)

Frequency of HLA‐DQ, susceptibility genotypes for celiac disease, in Brazilian newborns
por: Almeida, Fernanda C., et al.
Publicado: (2018)

Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
por: DeBiasi, Roberta L.
Publicado: (2021)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
por: Seo, Euri, et al.
Publicado: (2016)

Decreased Steroid Hormone Receptor NR4A2 Expression in Kawasaki Disease Before IVIG Treatment
por: Huang, Ying-Hsien, et al.
Publicado: (2019)

Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease
por: Inoue, Takashi, et al.
Publicado: (2020)

Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness
por: Niu, Man Man, et al.
Publicado: (2021)

Tenascin-C predicts IVIG non-responsiveness and coronary artery lesions in kawasaki disease in a Chinese cohort
por: Li, Yujie, et al.
Publicado: (2022)

Molecular evaluation of anti-inflammatory activity of phenolic lipid extracted from cashew nut shell liquid (CNSL)
por: de Souza, Marilen Queiroz, et al.
Publicado: (2018)

Updating the knowledge of sand flies (Diptera, Psychodidae) in Rondônia State, Brazil
por: Pereira Júnior, Antonio Marques, et al.
Publicado: (2022)

Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
por: De Groot, Anne S., et al.
Publicado: (2013)

Desensitization using IVIG alone for living-donor kidney transplant: impact on donor-specific antibodies
por: Ulisses, Luiz Roberto de Sousa, et al.
Publicado: (2022)

Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease
por: Li, Sung-Chou, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sn22qrhpm3gpb50gjlp9vq3nf2